We Can Do Better, Public Health Experts Say

Is it SARS-CoV-2? Influenza? RSV? Strep? In an unpredictable 2021-2022 respiratory season, prompt testing will tell the difference.

A 20-fold rise in the demand for molecular tests was seen in Europe and the United States between March 2020 and October 2020.¹

Quick access to accurate patient data is essential for treating patients efficiently. With point-of-care lab test results, clinicians can make more effective diagnosis and treatment plans.

Antibiotic resistance (AR) and overall antimicrobial resistance (AMR) is a complex issue that has currently reached a dangerous tipping point. Although frequently associated with antibiotics, AMR..

Immunoassays and molecular diagnostic tests are invaluable tools in the fields of oncology and infectious disease diagnostics. However, commercial and marketing leads must still make the most..

The morbidity and mortality statistics of COVID-19 have been well-studied. Less understood are the immediate and long-term ramifications of the pandemic on healthcare systems.